RACK1 and cancer: Specifically, SBSGL impedes HB tumour growth by inhibiting the O‐GlcNAcylation of RACK1, which is involved in multiple signalling pathways, affecting processes such as cell growth and migration and is aberrantly expressed in a wide range of malignant tumours.36